Matches in Wikidata for { <http://www.wikidata.org/entity/Q92419418> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q92419418 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92419418 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92419418 description "scientific article published on 14 March 2019" @default.
- Q92419418 description "wetenschappelijk artikel" @default.
- Q92419418 description "наукова стаття, опублікована 14 березня 2019" @default.
- Q92419418 name "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 name "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 type Item @default.
- Q92419418 label "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 label "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 prefLabel "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 prefLabel "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 P1433 Q92419418-C28064B3-C4BC-49ED-B763-50956335FF60 @default.
- Q92419418 P1476 Q92419418-89853B3C-208E-4F99-A5D3-CAA70722C988 @default.
- Q92419418 P2093 Q92419418-C0238E59-B5D4-4E2D-B6F7-9390E5ABC74B @default.
- Q92419418 P2093 Q92419418-E2E74D84-E93B-41EA-A4B2-ABD1530EABAD @default.
- Q92419418 P2093 Q92419418-EE540134-1DC1-49BA-B3EA-1266DC265A09 @default.
- Q92419418 P2093 Q92419418-F5A8A6F7-BE1F-4575-82A8-CCFFF9D8A1F5 @default.
- Q92419418 P2093 Q92419418-FDBDDDC0-8BC7-444E-99A8-BDD93F70C4B0 @default.
- Q92419418 P304 Q92419418-D4DC0888-C099-4819-B988-1D821F63F1A9 @default.
- Q92419418 P31 Q92419418-B5071210-3B32-4948-B939-FF195030E02A @default.
- Q92419418 P356 Q92419418-6A68EEC9-202F-480A-82ED-D12E44718205 @default.
- Q92419418 P433 Q92419418-125C5A44-54D0-457D-AE12-6DF7E6B5B88E @default.
- Q92419418 P478 Q92419418-E5435834-C66A-4D41-BF3F-5C49C027F852 @default.
- Q92419418 P577 Q92419418-4DB6ACFB-CF56-4874-A53D-1963E23918A2 @default.
- Q92419418 P698 Q92419418-24A5508A-E4E6-45DE-82A8-73EA150DE523 @default.
- Q92419418 P921 Q92419418-BD6E7ABF-1102-4555-99A6-7027E6957838 @default.
- Q92419418 P356 J.EURURO.2019.03.002 @default.
- Q92419418 P698 30879791 @default.
- Q92419418 P1433 Q15763991 @default.
- Q92419418 P1476 "Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" @default.
- Q92419418 P2093 "Declan G Murphy" @default.
- Q92419418 P2093 "Jiasian Teh" @default.
- Q92419418 P2093 "Niranjan Sathianathen" @default.
- Q92419418 P2093 "Stephen Schultz" @default.
- Q92419418 P2093 "Vignesh Narasimhan" @default.
- Q92419418 P304 "126-127" @default.
- Q92419418 P31 Q13442814 @default.
- Q92419418 P356 "10.1016/J.EURURO.2019.03.002" @default.
- Q92419418 P433 "1" @default.
- Q92419418 P478 "76" @default.
- Q92419418 P577 "2019-03-14T00:00:00Z" @default.
- Q92419418 P698 "30879791" @default.
- Q92419418 P921 Q13896859 @default.